# Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction

> **NCT02649712** · NA · COMPLETED · sponsor: **Xuzhou Central Hospital** · enrollment: 72 (actual)

## Conditions studied

- Cholangiocarcinoma
- Gallbladder Carcinoma
- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** biliary stent

## Key facts

- **NCT ID:** NCT02649712
- **Lead sponsor:** Xuzhou Central Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-20
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02649712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02649712, "Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02649712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*